THE ADHERENCE STATUS IN YOUNG ISCHEMIC HEART DISEASE PATIENTS AND ITS PREDICTOR
DOI:
https://doi.org/10.37268/mjphm/vol.25/no.1/art.3044Keywords:
Young ischemic heart disease, necrotising, compliance, suboptimal, medical recommendations, advice, recall, health belief modelAbstract
Ischemic heart disease (IHD) is the leading cause of cardiovascular-related premature death globally. However, young IHD patients are less likely to adhere to health recommendations. Thus, we aim to measure the adherence behaviour to the recalled health recommendations and related predictors. A cross-sectional study was conducted in a tertiary hospital from November 2021 to June 2022. Eligible young IHD patients were purposively sampled from outpatient cardiology clinics. They were evaluated using a validated self-administered questionnaire on sociodemographics, perceived severity of illness, health consciousness, eHealth literacy (eHEALS), and adherence to recalled health recommendations (MOSSAS). Patients with a MOSSAS score of < 5 are suboptimally adherent, while a score of ³ 5 is optimally adherent. Logistic regression modelling was used to determine the predictor towards suboptimal adherence behaviour. Of 136 participants, 73.5% were suboptimally adherent. Recall rates of health recommendations were highest for medication adherence (92.6% to 94.1%) and smoking cessation (94.1%), while the lowest was for regular exercise (53.7%). The least adhered recommendation was on socialising (20.0%), while reducing alcohol (72.1%) was the highest in those who scored ‘³ 5’. Only one predictor was identified through this study (type of IHD diagnosis). The odds of suboptimal adherence are higher (OR 3.765, 95% CI=1.227-11.551) in the necrotising type of IHD. Young IHD patients, especially those with necrotising type, have generally poor adherence to health recommendations. More focus and empowerment must be given to this group to prevent future graved complications.
References
Mensah GA, Fuster V, Murray CJL et al. Global Burden of Cardiovascular D, Risks C. Global Burden of Cardiovascular Diseases and Risks, 1990-2022. J Am Coll Cardiol. 2023;82(25):2350-473.
Nowbar AN, Gitto M, Howard JP et al. Mortality From Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes. 2019;12(6).
Tsao CW AA, Almarzooq ZI, Alonso A et al. Heart disease and stroke statistics—2022 update: a report from the American Heart Association. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2022; 26 January.
Wu P, Yu S, Wang Jet al. Global burden, trends, and inequalities of ischemic heart disease among young adults from 1990 to 2019: a population-based study. Front Cardiovasc Med. 2023;10.
Sun J, Qiao Y, Zhao M et al. Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15-39 years in 204 countries/territories, 1990-2019: a systematic analysis of Global Burden of Disease Study 2019. BMC Med. 2023;21(1):222.
Tong Z, Xie Y, Li K, Yuan R, Zhang L. The global burden and risk factors of cardiovascular diseases in adolescent and young adults, 1990-2019. BMC Public Health. 2024;24(1):1017.
Manla Y, Almahmeed W. The Pandemic of Coronary Heart Disease in the Middle East and North Africa: What Clinicians Need to Know. Curr Atheroscler Rep. 2023;25(9):543-57.
Hasani WSR, Muhamad NA, Hanis TM et al. The global estimate of premature cardiovascular mortality: a systematic review and meta-analysis of age-standardized mortality rate. BMC Public Health. 2023;23(1):1561.
Bloom DE, Chen S, Kuhn M et al. The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea. The Journal of the Economics of Ageing. 2020;17.
Ekinci G. Economic Impacts of Cardiovascular Diseases: An Econometric Evaluation in Turkey. Iran J Public Health. 2023;52(1):118-27.
Luengo-Fernandez R, Walli-Attaei M, Gray A et al. Economic burden of cardiovascular diseases in the European Union: a population-based cost study. European Heart Journal. 2023;44(45):4752-67.
